Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sienna CEO: IPO Investors Drawn By Experienced Dermatology Team

Aug 03 2017

• By Mandy Jackson

stock

Related Content

Finance Watch: Cash Flows Into Public Biopharmas, Including IPOs; Atlas Raises $350m VC Fund

Jul 06 2017

Finance Watch Public Company Edition: Akcea, Kala Launch IPOs While FOPOs Keep Busy Pace

Jul 21 2017

2017 IPOs In Review: US Biopharma Offerings Rise, Values Decline At Mid-Year

Jul 13 2017

Pfizer’s Eucrisa Approval By FDA Adds New Dermatology Anchor

Dec 14 2016

Itch-Focused Creabilis Finally Secures Its Future Through US Sale

Dec 08 2016

Pfizer Buys Anacor With Blockbuster Ambitions For Crisaborole

May 16 2016

Allergan buys chin fat firm Kythera for $2.1bn

Jun 18 2015

VC Roundup: 2Q Financings Fall As Per-Company Averages Rise

Jul 20 2016

IPO Update: Novan, AC Immune End Summer Slowdown As Market Improves

Sep 29 2016

Finance Watch: OncoMed Cuts Costs To Conserve Capital While Public, Private Peers Raise Cash

May 01 2017

Related Companies

Sienna Biopharmaceuticals, Inc.

Clementia Pharmaceuticals, Inc.

Akcea Therapeutics, Inc.

KALA BIO, Inc.

Allergan plc

Novartis AG

University of California, Los Angeles

Kythera Biopharmaceuticals, Inc.

Allergan plc

Allergan plc

Novan, Inc.

Pfizer Inc.

Anacor Pharmaceuticals, Inc.

Medicis Pharmaceutical Corporation

Additional Topics

Financing Business Strategies Commercial Companies Dermatology Aesthetics BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window